In-depth conversations with CEOs, CSOs, and leading experts shaping the future of cell & gene therapy. Real insights from people building, regulating, and investing in the next generation of medicines.
We're currently scheduling conversations with leading voices in cell & gene therapy. The first interviews will cover gene therapy manufacturing scale-up, FDA regulatory pathways, and investment strategies for early-stage gene therapy companies.
Want to be notified when new interviews drop?
Follow us on LinkedIn
or subscribe to The Gene Therapy Briefing, our bi-weekly newsletter.
Are you a leader in cell & gene therapy? We'd love to feature your perspective and share your insights with the CGT community.